A053950 Stock Overview
Kyung Nam Pharm Co.,Ltd. engages in the manufacture and sale of pharmaceutical, cosmetic, chemical, and health functional food products in South Korea, North America, and rest of Asia.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Kyung Nam Pharm Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩1,235.00 |
| 52 Week High | ₩2,515.00 |
| 52 Week Low | ₩1,135.00 |
| Beta | 0.14 |
| 1 Month Change | -9.12% |
| 3 Month Change | -3.36% |
| 1 Year Change | -27.57% |
| 3 Year Change | -82.63% |
| 5 Year Change | n/a |
| Change since IPO | -93.14% |
Recent News & Updates
Shareholder Returns
| A053950 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 2.8% | 1.5% | 2.7% |
| 1Y | -27.6% | 9.1% | 5.8% |
Return vs Industry: A053950 underperformed the KR Pharmaceuticals industry which returned 9.1% over the past year.
Return vs Market: A053950 underperformed the KR Market which returned 5.8% over the past year.
Price Volatility
| A053950 volatility | |
|---|---|
| A053950 Average Weekly Movement | 9.9% |
| Pharmaceuticals Industry Average Movement | 4.5% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in KR Market | 11.7% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A053950's share price has been volatile over the past 3 months.
Volatility Over Time: A053950's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 230 | Oh Hwan | www.kyungnampharm.co.kr |
Kyung Nam Pharm Co.,Ltd. engages in the manufacture and sale of pharmaceutical, cosmetic, chemical, and health functional food products in South Korea, North America, and rest of Asia. It also offers electronic, and agricultural and livestock products.
Kyung Nam Pharm Co.,Ltd. Fundamentals Summary
| A053950 fundamental statistics | |
|---|---|
| Market cap | ₩43.96b |
| Earnings (TTM) | -₩21.00b |
| Revenue (TTM) | ₩68.45b |
0.6x
P/S Ratio-2.1x
P/E RatioIs A053950 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A053950 income statement (TTM) | |
|---|---|
| Revenue | ₩68.45b |
| Cost of Revenue | ₩47.45b |
| Gross Profit | ₩21.00b |
| Other Expenses | ₩41.99b |
| Earnings | -₩21.00b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -589.92 |
| Gross Margin | 30.68% |
| Net Profit Margin | -30.68% |
| Debt/Equity Ratio | 56.2% |
How did A053950 perform over the long term?
See historical performance and comparison